COCRYSTAL PHARMA, INC. Goodwill
COCRYSTAL PHARMA, INC. (COCP) had Goodwill of $19.09 million as of 2022-03-31, per its 10-Q filed 2022-05-11.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2024-03-28
- 2022-03-31: Goodwill $19.09M.
- 2021-12-31: Goodwill $19.09M.
- 2021-09-30: Goodwill $19.09M.
- 2021-06-30: Goodwill $19.09M.
| Period end | Goodwill |
|---|---|
| 2022-03-31 | $19.09M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $19.09M 10-K · filed 2024-03-28 |
| 2021-09-30 | $19.09M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $19.09M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $19.09M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $19.09M 10-K · filed 2022-03-23 |
| 2020-09-30 | $19.09M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $19.09M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $19.09M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $19.09M 10-K · filed 2021-03-17 |
| 2019-09-30 | $65.19M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $65.19M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $65.19M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $65.19M 10-K · filed 2021-03-17 |
| 2018-09-30 | $65.19M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $65.19M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $65.19M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $65.19M 10-K · filed 2020-03-27 |
| 2017-09-30 | $65.19M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $65.19M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $65.19M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $65.19M 10-K · filed 2019-04-01 |
| 2016-09-30 | $65.19M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $65.19M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $65.19M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $65.19M 10-K · filed 2017-03-31 |
| 2015-09-30 | $65.19M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $65.19M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $65.19M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $65.19M 10-K · filed 2016-03-15 |
| 2013-09-30 | $1.03M 10-Q · filed 2013-11-18 |
| 2013-06-30 | $1.03M 10-Q · filed 2013-08-15 |
| 2013-03-31 | $1.03M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $1.03M 10-Q · filed 2013-11-18 |
| 2012-09-30 | $1.03M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $1.03M 10-Q/A · filed 2012-09-28 |
| 2012-03-31 | $1.03M 10-Q/A · filed 2012-10-02 |
| 2011-12-31 | $1.03M 10-K · filed 2013-04-01 |
| 2011-09-30 | $1.35M 10-Q · filed 2011-11-21 |
| 2011-06-30 | $1.30M 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |